INHIBITION OF ACID MUCOPOLYSACCHARIDE SYNTHESIS BY HYDROCORTISONE, HYDROCORTISONE 17-BUTYRATE AND BETAMETHASONE 17-VALERATE.SAARNI H; HOPSU HAVU VK.1977; BRIT. J. DERMATOL.; G.B.; DA. 1977; VOL. 97; NO 5; PP. 505-507; BIBL. 8 REF.Article

HYDROCORTISONE 17-BUTYRATE (LOCOIDREG.) 0.1% OINTMENT AND BETAMETHASONE 17-VALERATE (BETNOVATEREG.) 0.1% OINTMENT IN THE TREATMENT OF PATIENTS SUFFERING FROM PSORIASIS: A DOUBLE-BLIND, LEFT-RIGHT COMPARISONGIP L.1980; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1980; VOL. 28; NO 5; SECT. 1; PP. 596-599; BIBL. 6 REF.Article

The influence of cyclodextrin complexation on the stability of betamethasone-17-valerateANDERSEN, F. M; BUNDGAARD, H.International journal of pharmaceutics. 1984, Vol 20, Num 1-2, pp 155-162, issn 0378-5173Article

Etude clinique du tokderm dans les dermatoses gravesTAKEDA, K.Yakuri to chiryo. 1987, Vol 15, Num 12, pp 465-472, issn 0386-3603Article

TOPICAL BETAMETHASONE 17-VALERATE IS AN ANTICORTICOSTEROID IN THE RAT. I: DERMAL ATROPHYYOUNG JM; YOXALL BE; WAGNER BM et al.1978; BRIT. J. DERMATOL.; GBR; DA. 1978; VOL. 99; NO 6; PP. 655-663; BIBL. 10 REF.Article

THE STABILITY AND BLANCHING EFFICACITY OF BETAMETHASONE-17-VALERATE IN EMULSIFYING OINTMENTRYATT KS; FEATHER JW; MEHTA A et al.1982; BR. J. DERMATOL.; ISSN 0007-0963; GBR; DA. 1982; VOL. 107; NO 1; PP. 71-76; BIBL. 9 REF.Article

SIX-MONTH CONTROLLED STUDY OF EFFECT OF DESOXIMETASONE AND BETAMETHASONE 17-VALERATE ON THE PITUITARY-ADRENAL AXISCORNELL RC; STOUGHTON RB.1981; BR. J. DERMATOL. (1951); ISSN 0007-0963; GBR; DA. 1981; VOL. 105; NO 1; PP. 91-95; BIBL. 14 REF.Article

PENETRATION OF TOPICAL CORTICOSTEROIDS THROUGH HUMAN EPIDERMISOSAMURA H.1982; J. DERMATOL.; ISSN 0385-2407; JPN; DA. 1982; VOL. 9; NO 1; PP. 45-58; BIBL. 41 REF.Article

A DIFFERENTIAL KINETIC METHOD FOR THE DETERMINATION OF BETAMETHASONE-17-VALERATE IN THE PRESENCE OF ITS DEGRADATION PRODUCTSHANSEN J; BUNDGAARD H.1981; INT. J. PHARM.; ISSN 0378-5173; NLD; DA. 1981; VOL. 8; NO 2; PP. 121-129; BIBL. 17 REF.Article

A DOUBLE-BLIND CLINICAL STUDY TO COMPARE THE CLINICAL EFFICACY OF HYDROCORTISONE 17-BUTYRATE (LOCOIDREG.) OINTMENT WITH THAT OF BETAMETHASONE 17-VALERATE (BETNOVATEREG.) OINTMENT IN PATIENTS WITH NUMMULAR PSORIASISFREDRIKSSON DT.1980; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1980; VOL. 28; NO 5; SECT. 1; PP. 600-602; BIBL. 8 REF.Article

ESPERIENZE CLINICHE SULL' ALCINONIDE VERSUS BETAMETASONE 17 VALERATO IN DERMATOLOGIA = EXPERIENCES CLINIQUES DE L'ALCINONIDE ET DU BETAMETASONE 17 VALERATE EN DERMATOLOGIEGUARNERI B; GIARDINA A.1979; G. ITAL. DERMATOL., MINERVA DERMATOL.; ITA; DA. 1979; VOL. 114; SUPPL. 12; PP. 815-818; ABS. ENG; BIBL. 14 REF.Article

PENETRATION PERCUTANEE DE CORTICOSTEROIDES A PARTIR DE PREPARATIONS D'ACTIVITE THERMODYNAMIQUE IDENTIQUE.MOES HENSCHEL V; JAMINET F.1976; J. PHARM. BELG.; BELG.; DA. 1976; VOL. 31; NO 4; PP. 367-375; ABS. ANGL. NEERL.; BIBL. 4 REF.Article

Langerhans cells―a reduction in numbers and their reappearance following steroid and cytotoxic therapy in humansPAKES, W. L; MULLER, H. K; SCHWARZ, M. A et al.Clinical and experimental dermatology (Print). 1986, Vol 11, Num 5, pp 450-459, issn 0307-6938Article

In vitro diffusion cell design and validation. I: A stability-indicating high-performance liquid chromatographic assay for betamethasone 17-valerate in purified isopropyl myristate receptor phaseSMITH, E. W; HAIGH, J. M.Pharmaceutical research. 1989, Vol 6, Num 5, pp 431-435, issn 0724-8741Article

Symposium on topical corticosteroids today and tomorrow: augmented proceedings, Bali, 16-20 June 1988GIANNOTTI, B; STUTTGEN, G.Drugs (Basel). 1988, Vol 36, issn 0012-6667, V-61 p. [66 p.], suppl. 5Conference Proceedings

Domoprednate versus betamethasone-17-valerate ointments in the treatment of dermatosesSUHONEN, R.Current therapeutic research. 1986, Vol 40, Num 2, pp 342-344, issn 0011-393XArticle

A COMPARATIVE TRIAL OF LOCOID^REG. 0.1% CREAM AND BETNOVATE^REG. 0.1% CREAM IN PATIENTS SUFFERING FROM PSORIASISKROOK G.1983; CURRENT THERAPEUTIC RESEARCH; ISSN 0011-393X; USA; DA. 1983; VOL. 33; NO 1; PP. 57-61; BIBL. 7 REF.Article

Hydrocortisone 17-butyrate (locoid) 0.1% fatty cream and betamethasone 17-valerate (celestone valerate) 0.1% cream in the treatment of patients suffering from eczematous skin diseaseGIP, D. L.Current therapeutic research. 1983, Vol 34, Num 5, pp 813-817, issn 0011-393XArticle

A MULTI-CENTRE EVALUATION OF LOCOID^REG. AND CELESTONA^REG. VALERATE CREAMS IN THE TREATMENT OF PATIENTS SUFFERING FROM PSORIASISGIP DL.1982; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1982; VOL. 32; NO 3; PP. 464-468; BIBL. 4 REF.Article

Influence of topically applied betamethasone-17-valerate on cell cycle kinetics of human anagen hair determined by DNA flow cytometrySCHELL, H; KIESEWETTER, F; PAUSCH, C et al.Dermatologica. 1989, Vol 178, Num 1, pp 12-15, issn 0011-9075Article

A stability-indicating HPLC assay with on-line clean-up for betamethasone 17-valerate in topical dosage formsSMITH, E. W; HAIGH, J. M; KANFER, I et al.International journal of pharmaceutics. 1985, Vol 27, Num 2-3, pp 185-192, issn 0378-5173Article

Efficacy of Locoid-C and Betnovate-C ointments in secondarily infected eczema: a double-blind studyDA FONSECA, N; AMARAL, C.Current therapeutic research. 1983, Vol 34, Num 4, pp 735-739, issn 0011-393XArticle

Hydrocortisone 17-butyrate 0.1 % lipocream versus betamethasone 17-valerate 0.1 % cream in the treatment of patients with dry severe chronic eczemaGIP, L; VERJANS, H. L.Current therapeutic research. 1987, Vol 41, Num 2, pp 258-264, issn 0011-393XArticle